PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 15 filers reported holding PHIO PHARMACEUTICALS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $57,487 | -54.0% | 154,536 | -29.2% | 0.00% | – |
| Q3 2022 | $125,000 | -40.5% | 218,192 | -26.8% | 0.00% | – |
| Q2 2022 | $210,000 | -21.9% | 297,971 | -2.0% | 0.00% | – |
| Q1 2022 | $269,000 | -5.6% | 304,119 | +6.8% | 0.00% | – |
| Q4 2021 | $285,000 | -50.7% | 284,877 | 0.0% | 0.00% | – |
| Q3 2021 | $578,000 | -7.5% | 284,877 | +3.0% | 0.00% | – |
| Q2 2021 | $625,000 | +90.0% | 276,561 | +125.4% | 0.00% | – |
| Q1 2021 | $329,000 | +66.2% | 122,697 | +67.0% | 0.00% | – |
| Q4 2020 | $198,000 | – | 73,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 154,536 | $57,487 | 0.00% |
| UBS Group AG | 23,029 | $8,521 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 22,398 | $8,332 | 0.00% |
| Cetera Investment Advisers | 75,000 | $27,900 | 0.00% |
| WELLS FARGO & COMPANY/MN | 93 | $35 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 106,917 | $39 | 0.00% |
| MORGAN STANLEY | 1,500 | $558 | 0.00% |
| BlackRock Inc. | 19 | $7 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 19,707 | $7,331 | 0.00% |